{"answers":{"affected":"It affects 1 product.","exploited":"There is no known exploitation of CVE-2017-17678 in the wild and no public exploit code.","fix":"No fix has been published for CVE-2017-17678 yet. Limit exposure of the affected software until one is available.","what":"CVE-2017-17678 is a medium-severity cross-site scripting vulnerability in n/a, published on 19 May 2021. An attacker can exploit it over the internet without logging in, and only if a user opens a file or follows a link."},"fix_prompt":"Check this codebase for CVE-2017-17678 and fix it if it is affected.\n\nWhat it is: CVE-2017-17678 is a medium-severity cross-site scripting vulnerability in n/a, published on 19 May 2021. An attacker can exploit it over the internet without logging in, and only if a user opens a file or follows a link.\nExploitation: There is no known exploitation of CVE-2017-17678 in the wild and no public exploit code.\n\nAffected product: n/a. No package-level version data is available, so check the vendor advisory linked from the reference page.\n\nTask:\n1. Search the dependency manifests and lockfiles (for example package.json, package-lock.json, requirements.txt, poetry.lock, uv.lock, pom.xml, build.gradle, go.mod, Cargo.lock, Gemfile.lock) and any Dockerfiles for the affected packages, including transitive dependencies.\n2. If an affected version is in use, upgrade it to the fixed version for its release line with the project's package manager, so the lockfile is regenerated. Prefer the smallest upgrade that fixes it.\n3. If there is no fix, or the upgrade would break the build, do not guess: explain the risk and the safest workaround instead.\n4. Run the tests and summarise what changed and why.\n5. If nothing in the project is affected, say so and change nothing.\n\nReference: https://insights.sbomify.com/CVE-2017-17678/ (Markdown: https://insights.sbomify.com/CVE-2017-17678/index.md)","id":"CVE-2017-17678","markdown":"https://insights.sbomify.com/CVE-2017-17678/index.md","name":"CVE-2017-17678","record":{"aliases":["GHSA-w2cx-4cp9-hmm4"],"analysis":{"component_type":"web_application","fix_type":"patch","impacts":["code_execution","account_takeover"],"network_reachable":"yes","non_default_config":false,"product_category":"BMC Remedy Mid Tier","requires_auth":"none","summary":"A DOM-based cross-site scripting vulnerability in BMC Remedy Mid Tier allows attackers to inject malicious scripts into web pages viewed by other users.","user_interaction":"required","vuln_class":"xss"},"analysis_generated_by":"qwen3.8-flash-next","assigner":"mitre","cpe":[{"product":"remedy_mid-tier","vendor":"bmc"}],"cvss":{"score":6.1,"severity":"medium","source":"nvd","vector":"CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N","version":"3.1"},"cwes":[{"id":"CWE-79","name":"Improper Neutralization of Input During Web Page Generation"}],"description":"BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS). A DOM-based cross-site scripting vulnerability was discovered in a legacy utility.","ecosystems":[],"exploits":{"exploitdb":0,"first_seen":null,"github_poc":0,"max_poc_stars":null,"metasploit":0,"nuclei":0,"refs":[],"tier":"none_known"},"has_fix":null,"headline":"Cross-site scripting in n/a","id":"CVE-2017-17678","indexable":true,"kev":null,"kind":"cve","links":{"ecosystem":null,"product":null,"products":[],"type":"xss","year":"2017"},"n_packages":0,"n_references":2,"next":{"headline":"Denial of service in n/a","id":"CVE-2017-17680"},"packages":[],"prev":{"headline":"Code injection in n/a","id":"CVE-2017-17677"},"products":["n/a"],"published":"2021-05-19","related":[{"cvss_score":9.8,"headline":"Auth bypass in n/a","id":"CVE-2024-34399","kev_date_added":null,"published":"2024-09-18"},{"cvss_score":9.8,"headline":"Server-side request forgery in n/a","id":"CVE-2017-17674","kev_date_added":null,"published":"2021-05-19"},{"cvss_score":8.8,"headline":"Code injection in n/a","id":"CVE-2017-17677","kev_date_added":null,"published":"2021-05-19"},{"cvss_score":5.3,"headline":"Information disclosure in n/a","id":"CVE-2017-17675","kev_date_added":null,"published":"2021-05-19"},{"cvss_score":4.2,"headline":"Cross-site scripting in n/a","id":"CVE-2024-34398","kev_date_added":null,"published":"2025-03-12"}],"sources":[{"class":"attribution","licence":"CVE Terms of Use (MITRE)","name":"CVE List","prefix":"CVE"},{"class":"attribution","licence":"US public information, NVD API terms","name":"NVD"},{"class":"attribution","licence":"CWE Terms of Use","name":"CWE (MITRE)"},{"class":"attribution","licence":"FIRST CVSS licence","name":"CVSS (FIRST)"}],"ssvc":{"automatable":null,"exploitation":null,"technical_impact":null},"state":"PUBLISHED","updated":"2026-07-09","vendors":["n/a"]},"summary":"A DOM-based cross-site scripting vulnerability in BMC Remedy Mid Tier allows attackers to inject malicious scripts into web pages viewed by other users.","url":"https://insights.sbomify.com/CVE-2017-17678/"}